Topic

New York

A collection of 516 issues

How to Get Prolastin-C Approved by Humana in New York: Timeline, Appeals, and Step-by-Step Guide

Answer Box: Getting Prolastin-C Covered by Humana in New York Fastest path to approval: Submit prior authorization with documented severe AAT deficiency (Pi*ZZ genotype), failed Aralast trial, and specialist consultation. Humana must respond within 14 days for standard requests, 72 hours for expedited. If denied, file internal appeal within

How to Get Hemlibra (Emicizumab) Covered by UnitedHealthcare in New York: Complete Cost-Cutting Guide

Answer Box: Getting Hemlibra Covered by UnitedHealthcare in New York Hemlibra (emicizumab) requires prior authorization from UnitedHealthcare, dispensed through specialty pharmacy (typically Optum), with commercial patients eligible for up to $15,000 annual copay assistance. Key requirements: confirmed hemophilia A diagnosis, inhibitor status documentation, and prophylaxis indication. If denied, New

Coding That Helps Get Poteligeo (mogamulizumab-kpkc) Approved in New York with Aetna (CVS Health): ICD-10, HCPCS J-Code, and NDC Requirements

Answer Box: Getting Poteligeo Covered by Aetna in New York Key codes needed: ICD-10 C84.0x (mycosis fungoides) or C84.1x (Sézary syndrome), HCPCS J9204, NDC 42388-0302-01. Fastest path: Submit prior authorization with accurate weight-based dosing calculation (1 mg/kg), documented prior systemic therapy failure, and staging details. First step

How to Get Uplizna (Inebilizumab) Covered by Cigna in New York: Complete Appeals Guide

Answer Box: Your Path to Uplizna Coverage Eligibility: Cigna covers Uplizna (inebilizumab) for AQP4-positive NMOSD and IgG4-related disease with prior authorization. Fastest path: Neurologist submits PA with AQP4-positive labs, HBV screening (negative), and relapse history via Cigna provider portal. Start today: Gather your AQP4 antibody results and HBV test; if

Getting Therakos CELLEX Photopheresis Covered by Humana in New York: Prior Authorization Guide and Appeal Scripts

Answer Box: Getting Started Humana requires prior authorization for Therakos CELLEX photopheresis in New York for CTCL and steroid-refractory GVHD. Submit documentation through Humana's provider portal showing failed prior therapies and specialist oversight. If denied, you have 65 days to appeal internally, then 45 days for New York&

How to Get Trikafta Covered by Cigna in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Trikafta Covered by Cigna in New York Cigna requires prior authorization for Trikafta (elexacaftor/tezacaftor/ivacaftor) in New York. Approval depends on confirmed cystic fibrosis diagnosis with documented CFTR mutation (especially F508del), prescription by a CF specialist, and complete clinical documentation. If denied, New York's

Bylvay (Odevixibat) Approval with Humana in New York: Complete Guide to Prior Authorization, Appeals, and Coverage Requirements

Answer Box: How to Get Bylvay (Odevixibat) Covered by Humana in New York Bylvay (odevixibat) requires prior authorization from Humana for both PFIC and Alagille syndrome. Your hepatologist or gastroenterologist must submit documentation including genetic confirmation, pruritus severity, and prior treatment failures. Three steps to start today: (1) Confirm your

How to Get Trikafta Covered by Aetna CVS Health in New York: Complete Prior Authorization and Appeals Guide

Quick Answer: Trikafta requires prior authorization through Aetna CVS Health in New York. Submit requests via EviCore healthcare at least 2 weeks before treatment. Required: CFTR genotype testing showing F508del or eligible mutations, CF diagnosis (ICD-10: E84.0), and pulmonologist documentation. If denied, you have 180 days for internal appeals

How to Get Cometriq (Cabozantinib) Covered by Cigna in New York: Prior Authorization, Appeals & Cost Assistance

Answer Box: Getting Cometriq (Cabozantinib) Covered by Cigna in New York Cometriq requires prior authorization from Cigna and must be dispensed through specialty pharmacy. The fastest path: 1) Have your oncologist submit a complete PA request with diagnosis, treatment history, and clinical rationale within 72 hours, 2) If denied, file

How to Get Vitrakvi (Larotrectinib) Covered by Humana in New York: PA Requirements, Appeals, and External Review Guide

Answer Box: Getting Vitrakvi Covered by Humana in New York Vitrakvi (larotrectinib) is covered on Humana's Medicare Advantage formulary but requires prior authorization. Your oncologist must submit documentation proving NTRK gene fusion positivity, metastatic/unresectable disease, and prior therapy history. If denied, you have 65 days to appeal